A novel putative interactor for the low density lipoprotein receptor cytoplasmic domain

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder primarily linked to LDL receptor (LDL-R) gene mutations.
• FH-like phenotypes can result from mutations in genes encoding proteins that interact with the LDL receptor.
• Numerous FH cases remain unexplained, suggesting undiscovered genes involved in LDL receptor function.

Purpose of the Study:

• To identify novel proteins interacting with the LDL receptor, particularly those involved in its internalization and sorting.
• To investigate potential genetic causes of FH-like phenotypes linked to unknown LDL receptor interactors.

Main Methods:

• Yeast two-hybrid assay utilizing the cytoplasmic tail of the LDL receptor as bait.
• Identification of interacting proteins through screening.

Main Results:

• An 85-amino acid protein was identified that binds to the intracellular domain of the LDL receptor.
• The binding interaction involves the final 14 C-terminal amino acids of the novel protein.
• This protein is likely translated from an alternative open reading frame within the human MT2A gene.

Conclusions:

• A novel LDL receptor-interacting protein has been discovered.
• This protein, potentially encoded by the MT2A gene, may play a role in LDL receptor regulation.
• Further research into this protein could elucidate mechanisms underlying familial hypercholesterolemia and identify new therapeutic targets.